Abstract:Abstract Background/Aims There are often significant delays to the diagnosis of axial spondyloarthritis (AxSpA). The imaging modality of choice to investigate for AxSpA is an MRI with a specific AxSpA protocol (MRI AS protocol). A common route of referral for MRI scans looking for AxSpA is via the community physiotherapy team. The Spondyloarthritis Diagnosis Evaluation (SPADE) tool has been designed to estimate the probability of patients having AxSpA. This study aimed to look at the relationship between SPADE tool probability score and MRI AS protocol results in patients who were referred from community physiotherapy. Methods This was a retrospective service evaluation. The sample was obtained from 200 MRI AS protocol requests between 6 January 2020 and 15 December 2021. For each patient, the MRI result was obtained from ICE electronic results software. MRI results were categorised as AxSpA, not AxSpA, or equivocal. For equivocal results, electronic patient notes were reviewed to identify whether patients went on to be diagnosed with AxSpA. The patient SPADE score (improbable, additional tests necessary, probable diagnosis, or definite diagnosis) was recorded for each patient. Information was obtained from the electronic physiotherapy notes to determine a SPADE score. Results Of the 200 scans requested, 21 scans were excluded (eight due to AS protocol not being performed; six due to duplicate requests; four not investigating for AxSpA; two where radiology had suggested MRI AS protocol; one patient awaiting recall for a repeat scan). Of the 179 patients who had MRI scans, 9.5% (n = 17) showed AxSpA, 8.9% were equivocal (n = 16) and 81.6% (n = 146) were negative. A SPADE score was determined for 177 patients (two had insufficient data to determine a score). 30% (n = 53) of patients were ‘improbable’, 56% (n = 99) were ‘additional tests necessary’, 8% (n = 14) were ‘probable’ and 6% (n = 11) were ‘definite’. Of the ‘improbable’ cases, three had MRI demonstrating AxSpA and one was equivocal (4/53 [7.5%]). 49 patients had no MRI evidence of AxSpA. Of the patients with MRI positive scans, 3/17 (17.6%) were ‘improbable’ using the SPADE tool. Conclusion Having a tool to screen patients in the community may help to better identify those who warrant further investigation for AxSpA. The SPADE tool may be a useful aid to identify who to refer for further investigation of inflammatory back pain. Many patients identified as ‘improbable’ by the SPADE tool did not have evidence of AxSpA. If the tool was applied prospectively, this may lead to large reduction in the number of MRI AS protocol scans performed. However, there were a small number of ‘improbable’ cases who had MRI evidence of AxSpA and could therefore be misdiagnosed as non-inflammatory back pain. Disclosure T. Nadin: None. S. Crompton: None. A. Chopra: None. N. Kotnis: None. L. Dunkley: Honoraria; Abbvie, UCB, Pfizer and Novartis. Other; Speakers fees from Abbvie, UCB, Pfizer and Novartis.

Screening Tools for Spondyloarthritis in Patients with Psoriasis, Uveitis, and Inflammatory Bowel Disease – A Scoping Review

Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study

A scoping review of triage approaches for the referral of patients with suspected inflammatory arthritis, from primary to rheumatology care

P084 The prevalence of inflammatory back pain in a secondary care psoriasis cohort

Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA

Screening of psoriatic arthritis by dermatologists - a German nationwide survey

Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis—a systematic literature review and meta-analysis

OA07 Is the SPADE tool a suitable way of screening patients for possible axial spondyloarthropathy

Features of Axial Spondyloarthritis in Two Multicenter Cohorts of Patients with Psoriasis, Uveitis, and Colitis Presenting with Undiagnosed Back Pain

A clinical practice guideline for the screening and assessment of enthesitis in patients with spondyloarthritis

Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis Registry

Comparative evaluation of screening tools for sarcopenia in patients with axial spondyloarthritis

Screening tools assessing mental illness in primary care: A systematic review

DOP60 Prevalence of undiagnosed inflammatory Bowel Disease in patients with spondyloarthritis: EISER Study

Frequency of irritable bowel syndrome in spondyloarthritis: a multicentric cross-sectional study and meta-analysis

Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis

Screening for Behavioral Health Conditions in Primary Care Settings: A Systematic Review of the Literature

Psychosocial Well-Being and Quality of Life in Uveitis: A Review

Pre-assessment of patients with suspected axial spondyloarthritis combining student-led clinics and telemedicine: a qualitative study

Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project

Treatment strategies for Spondyloarthritis: Implementation of precision medicine - Or "one size fits all" concept?